Cycurion is trading 10.87% higher at $2.54, with no confirmed company-specific catalyst explaining the move.

  • The latest reported company updates predate the session, including an October 20 shareholder letter and a November 16 earnings-call announcement.
  • The broader market is mixed as investors await the Federal Reserve decision; available evidence does not establish a market-wide catalyst for Cycurion’s gain.